人工瓣膜置换术后感染的危险因素分析及预防策略

董柱, 曹一秋, 张本, 等. 人工瓣膜置换术后感染的危险因素分析及预防策略[J]. 临床心血管病杂志, 2019, 35(4): 300-305. doi: 10.13201/j.issn.1001-1439.2019.04.003
引用本文: 董柱, 曹一秋, 张本, 等. 人工瓣膜置换术后感染的危险因素分析及预防策略[J]. 临床心血管病杂志, 2019, 35(4): 300-305. doi: 10.13201/j.issn.1001-1439.2019.04.003
DONG Zhu, CAO Yiqiu, ZHANG Ben, et al. Analysis of risk factors for infection and prevention strategy after heart valve replacement[J]. J Clin Cardiol, 2019, 35(4): 300-305. doi: 10.13201/j.issn.1001-1439.2019.04.003
Citation: DONG Zhu, CAO Yiqiu, ZHANG Ben, et al. Analysis of risk factors for infection and prevention strategy after heart valve replacement[J]. J Clin Cardiol, 2019, 35(4): 300-305. doi: 10.13201/j.issn.1001-1439.2019.04.003

人工瓣膜置换术后感染的危险因素分析及预防策略

  • 基金项目:

    国家自然科学基金项目(No:81671885);广州市科技计划项目(No:201707010066);广州市珠江科技新星专项(No:201610010094)

详细信息
    通讯作者: 王晓武,E-mail:xzwk_wxw@hotmail.com
  • 中图分类号: R541.6

Analysis of risk factors for infection and prevention strategy after heart valve replacement

More Information
  • 目的:回顾性总结444例瓣膜置换围术期治疗效果,分析术后感染发病率、种类及相关影响因素,探究心脏瓣膜置换术后感染的主要危险因素及预防策略。方法:回顾性分析本中心2013-07-2018-07行心脏瓣膜置换术的患者444例,其中男209例,女235例,年龄(49.62±12.92)岁;根据围术期感染标准将术后患者分为感染组(71例),非感染组(373例),总结围手术期的各项数据及资料,采用单因素分析得出危险因素并纳入多因素Logistic回归以明确独立危险因素。结果:围术期死亡7例(1.6%),其中感染组死亡5例(7.0%),非感染组死亡2例(0.5%),两组病死率差异有统计学意义(P<0.001)。死亡原因包括低心排综合征5例,多器官功能衰竭2例。围术期感染71例,感染率15.9%,包括肺部感染61例(85.9%),肠道感染3例(4.2%),泌尿系感染2例(2.8%),心内膜感染5例(7.1%);感染组与非感染组单因素分析提示老年、男性、肥胖、糖尿病、吸烟、血脂异常、术前感染病史、术前肝肾功能异常、术前心功能、病程时限、手术时间、体外循环时间、升主动脉阻断时间、术中出血量、气管插管时间与瓣膜置换术后感染有关,而经Logistic回归分析进一步明确肥胖(OR:5.777;P<0.05)、糖尿病(OR:7.071;P<0.05)、术前感染病史(OR:29.953;P<0.01)、术前肝功能异常(OR:20.546;P<0.01)、病程>10年(OR:5.091;P<0.01)、手术时间(OR:1.969;P<0.01)、升主动脉阻断时间(OR:1.070;P<0.05)、气管插管时间(OR:3.989;P<0.01)为瓣膜置换术后感染的独立危险因素。ROC曲线分析得出,气管插管时间预测瓣膜置换术后感染的效能最高。结论:明确肥胖、糖尿病、术前感染病史、术前肝功能异常、病程>10年、手术时间、升主动脉阻断时间、气管插管时间是术后感染危险因素;围手术期对患者实施综合评估和干预措施,可降低瓣膜置换术后感染风险、提高早期生存率。
  • 加载中
  • [1]

    刘建民, 刘达兴, 夏宇, 等.心脏瓣膜置换术后肺部并发症的多因素分析[J].遵义医学院学报, 2017, 46(6):673-677.

    [2]

    张梅, 徐铭俊.心瓣膜疾病介入术中的慧眼——超声心动图的应用[J].临床心血管病杂志, 2018, 34(12):1145-1149.

    [3]

    Zhang XW, Song ZG, Wang L, et al.The use of intra-aortic balloon pump in patients undergoing heart valve replacement:Outcome and risk analysis[J].J Heart Valve Dis, 2014, 23(4):458-462.

    [4]

    Weimar T, Roser D, Liebrich M, et al.Strategies for biological heart valve replacement:Stentless xenografts fail to evolve into an alternative pulmonary valve substitute in a Ross procedure[J].Biotechnol J, 2013, 8(3):345-351.

    [5]

    Durack DT, Luk es AS, Brigh t DK, et al.New criteria for diagnosis of infective endocarditis:utilization of specific echocardiographic findings.Duke Endocarditis Service[J].Am J Med, 1994, 96(3):200-209.

    [6]

    Riera M, Ibá?ez J, Herrero J, et al.Respiratory tract infections after cardiac surgery:Impact on hospital morbidity and mortality[J].J Cardiovasc Surg (Torino), 2010, 51(6):907-914.

    [7]

    Farran L, Llop J, Sans M, et al.Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery[J].Dis Esophagus, 2008, 21(2):159-164.

    [8]

    Phan K, Tsai YC, Niranjan N, et al.Sutureless aortic valve replacement:A systematic review and meta-analysis[J].Ann Cardiothorac Surg, 2015.4(2):100-111.

    [9]

    Cai XH.Risk factors for nosocomial pulmonary infection after tracheal intubation under general anesthesia[J].Chin J Nosocomiology, 2011, 9:1780-1782.

    [10]

    Flynn DM, Weinstein RA, Kabins SA.Infections with gram-negative bacilli in a cardiac surgery intensive care unit:the relative role of Enterobacter[J].J Hosp Infect, 1988, 11 Suppl A:367-373.

    [11]

    Witten JC, Hussain ST, Shrestha NK, et al.Surgical treatment of right-sided infective endocarditis[J].J Thorac Cardiovasc Surg, 2018, 5223(18):32475-9.

    [12]

    Cahill TJ, Baddour LM, Habib G, et al.Challenges in infective endocarditis[J].J Am Coll Cardiol, 2017, 69(3):325-344.

    [13]

    严赖莎, 赵顺英, 胡晓燕, 等.瓣膜置换术后高血糖与新发心房颤动的关系[J].临床心血管病杂志, 2018, 34(10):1002-1005.

    [14]

    汪贵清, 陈小瑞, 肖松林, 等.体质指数对合并2型糖尿病的心力衰竭患者预后的影响[J].临床心血管病杂志, 2017, 33(2):157-161.

    [15]

    Ji Q, Mei YQ, Wang XS, et al.Risk factors for pulmonarycomplications follow cardiac surgery with cardiopulmonary bypass[J].Int J Med Sci, 2013, 10(11):1578-1583.

    [16]

    Falagas ME, Kompoti M.Obesity and infection[J].Lancet Infect Dis, 2006, 6(7):438-446.

    [17]

    Lola I, Levidiotou S, Petrou A, et al.Are there independent predisposing factors for postoperative infections following open heart surgery?[J].J Cardiothorac Surg, 2011, 14(6):151-151.

    [18]

    Sato H, Carvalho G, Sato T, et al.The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery[J].J Clin Endocrinol Metab, 2010, 95(9):4338-4344.

    [19]

    Vermeulen WI, Hanssen SJ, Buurman WA, et al.Cardiovascular surgery and organ damage:time to reconsider the role of hemolysis[J].J Thorac Cardiovasc Surg, 2011, 142(1):1-11.

    [20]

    Qiu Z, Chen L, Cao H, et al.Analysis of risk factors foracute kidney injury after ascending aortic replacement combined with open placement of triple-branched stent graftin type A aortic dissection:a new technique versus the traditional method in a single Chinese center[J].Med SciMonit, 2015, 21:674-680.

    [21]

    Schanz O, Wohlleber D, Abdullah Z, et al.Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity[J].Cell Reports, 2013, 3(3):779-795.

  • 加载中
计量
  • 文章访问数:  256
  • PDF下载数:  207
  • 施引文献:  0
出版历程
收稿日期:  2018-12-03

目录